/Equities/AIMX/CRTX/RNS

Secondary share class. The ordinary shares trade as AMC (Amur Minerals Corporation). Director, financial and RNS data shown here are for the issuer.

Crism Therapeutics Corporation RNS

/Equities/AIMX/CRTX/RNS

Secondary share class. The ordinary shares trade as AMC (Amur Minerals Corporation). Director, financial and RNS data shown here are for the issuer.

Crism Therapeutics Corporation RNS

/Equities/AIMX/CRTX/RNS

Secondary share class. The ordinary shares trade as AMC (Amur Minerals Corporation). Director, financial and RNS data shown here are for the issuer.

/Equities/AIMX/CRTX/RNS

Secondary share class. The ordinary shares trade as AMC (Amur Minerals Corporation). Director, financial and RNS data shown here are for the issuer.

Crism Therapeutics Corporation RNS

Date	Time	Date	TitleTitle (filtered)
02/07/26	16:31:03	2 Jul 2026	Holding(s) in Company	Holding(s) in Company
30/06/26	15:30:01	30 Jun 2026	Grant of Options	Grant of Options
26/06/26	07:00:03	26 Jun 2026	FINAL RESULTS	FINAL RESULTS
25/06/26	07:00:03	25 Jun 2026	Phase 2 Clinical Trial Progress Update	Phase 2 Clinical Trial Progress Update
22/06/26	08:49:42	22 Jun 2026	Holding(s) in Company	Holding(s) in Company
16/06/26	17:13:24	16 Jun 2026	Holding(s) in Company	Holding(s) in Company
15/06/26	11:15:01	15 Jun 2026	Result of General Meeting	Result of General Meeting
04/06/26	07:00:05	4 Jun 2026	Significant Grant Award	Significant Grant Award
01/06/26	07:00:12	1 Jun 2026	Grant Award	Grant Award
28/05/26	13:35:57	28 May 2026	Result of Retail Offer	Result of Retail Offer
27/05/26	09:34:33	27 May 2026	Notice of General Meeting	Notice of General Meeting
26/05/26	07:01:00	26 May 2026	Retail Offer to raise up to £100,000	Retail Offer to raise up to £100,000
26/05/26	07:00:14	26 May 2026	Placing of £2.5 million	Placing of £2.5 million
21/04/26	07:00:03	21 Apr 2026	Positive Preclinical Data for Docetaxel ChemoSeed	Positive Preclinical Data for Docetaxel ChemoSeed
02/04/26	07:00:05	2 Apr 2026	Board Changes	Board Changes
25/03/26	07:00:01	25 Mar 2026	Phase 2 Clinical Trial Progress Update	Phase 2 Clinical Trial Progress Update
17/03/26	07:00:14	17 Mar 2026	Awarding of Orphan Drug Designation by the FDA	Awarding of Orphan Drug Designation by the FDA
20/01/26	07:00:10	20 Jan 2026	Japanese Patent Grant	Japanese Patent Grant
09/01/26	07:00:06	9 Jan 2026	Results of Shareholder Analysis	Results of Shareholder Analysis
15/12/25	14:29:32	15 Dec 2025	Result of Retail Offer	Result of Retail Offer
10/12/25	07:25:01	10 Dec 2025	Retail Offer	Retail Offer
10/12/25	07:00:09	10 Dec 2025	Placing of £1,000,000	Placing of £1,000,000
27/11/25	07:00:14	27 Nov 2025	Holding(s) in Company	Holding(s) in Company
30/10/25	07:00:11	30 Oct 2025	US Orphan Drug Designation Application	US Orphan Drug Designation Application
14/10/25	07:00:10	14 Oct 2025	Positive Preclinical Data in Prostate Cancer	Positive Preclinical Data in Prostate Cancer
15/09/25	07:00:10	15 Sept 2025	Half Year Report	Half Year Report
12/09/25	07:00:18	12 Sept 2025	Notice of Interim Results and IMC Presentation	Notice of Interim Results and IMC Presentation
01/09/25	07:00:10	1 Sept 2025	Approval for phase 2 clinical trial	Approval for phase 2 clinical trial
26/08/25	16:03:57	26 Aug 2025	Result of AGM	Result of AGM
26/08/25	07:00:06	26 Aug 2025	AGM Statement	AGM Statement
12/08/25	07:00:06	12 Aug 2025	GMP Manufacture of ChemoSeed	GMP Manufacture of ChemoSeed
04/08/25	17:45:00	4 Aug 2025	Notice of AGM and EMI Option Plan	Notice of AGM and EMI Option Plan
10/07/25	15:04:12	10 Jul 2025	Holding(s) in Company	Holding(s) in Company
03/07/25	07:00:10	3 Jul 2025	Result of Retail Offer and Additional Placing	Result of Retail Offer and Additional Placing
01/07/25	16:41:13	1 Jul 2025	Update presentation on the IMC platform	Update presentation on the IMC platform
01/07/25	07:00:08	1 Jul 2025	Submission of CTA Application	Submission of CTA Application
30/06/25	07:01:00	30 Jun 2025	Retail Offer	Retail Offer
30/06/25	07:00:11	30 Jun 2025	Placing	Placing
13/06/25	07:00:09	13 Jun 2025	Final Results for the year ended 31 December 2024	Final Results for the year ended 31 December 2024
09/06/25	07:00:10	9 Jun 2025	Best Paper Award	Best Paper Award
03/06/25	07:00:07	3 Jun 2025	Establishment of Scientific Advisory Board	Establishment of Scientific Advisory Board
07/04/25	11:46:21	7 Apr 2025	Director Dealing	Director Dealing
31/03/25	07:00:13	31 Mar 2025	Clinical Trial Update	Clinical Trial Update
27/03/25	07:00:04	27 Mar 2025	Innovate UK Grant Award	Innovate UK Grant Award
20/12/24	07:00:04	20 Dec 2024	Appointment of Specialist Clinical CRO	Appointment of Specialist Clinical CRO
18/12/24	07:00:02	18 Dec 2024	European Patent Grant	European Patent Grant
19/09/24	07:00:03	19 Sept 2024	Interim Results	Interim Results
09/09/24	07:00:10	9 Sept 2024	Notice of Interim Results & IMC Presentation	Notice of Interim Results & IMC Presentation
03/09/24	07:00:11	3 Sept 2024	Delivery Method Validated in Peer Reviewed Journal	Delivery Method Validated in Peer Reviewed Journal
02/09/24	07:00:09	2 Sept 2024	Innovation Passport Award	Innovation Passport Award

Date	Time	Date	TitleTitle (filtered)
02/07/26	16:31:03	2 Jul 2026	Holding(s) in Company	Holding(s) in Company
30/06/26	15:30:01	30 Jun 2026	Grant of Options	Grant of Options
26/06/26	07:00:03	26 Jun 2026	FINAL RESULTS	FINAL RESULTS
25/06/26	07:00:03	25 Jun 2026	Phase 2 Clinical Trial Progress Update	Phase 2 Clinical Trial Progress Update
22/06/26	08:49:42	22 Jun 2026	Holding(s) in Company	Holding(s) in Company
16/06/26	17:13:24	16 Jun 2026	Holding(s) in Company	Holding(s) in Company
15/06/26	11:15:01	15 Jun 2026	Result of General Meeting	Result of General Meeting
04/06/26	07:00:05	4 Jun 2026	Significant Grant Award	Significant Grant Award
01/06/26	07:00:12	1 Jun 2026	Grant Award	Grant Award
28/05/26	13:35:57	28 May 2026	Result of Retail Offer	Result of Retail Offer
27/05/26	09:34:33	27 May 2026	Notice of General Meeting	Notice of General Meeting
26/05/26	07:01:00	26 May 2026	Retail Offer to raise up to £100,000	Retail Offer to raise up to £100,000
26/05/26	07:00:14	26 May 2026	Placing of £2.5 million	Placing of £2.5 million
21/04/26	07:00:03	21 Apr 2026	Positive Preclinical Data for Docetaxel ChemoSeed	Positive Preclinical Data for Docetaxel ChemoSeed
02/04/26	07:00:05	2 Apr 2026	Board Changes	Board Changes
25/03/26	07:00:01	25 Mar 2026	Phase 2 Clinical Trial Progress Update	Phase 2 Clinical Trial Progress Update
17/03/26	07:00:14	17 Mar 2026	Awarding of Orphan Drug Designation by the FDA	Awarding of Orphan Drug Designation by the FDA
20/01/26	07:00:10	20 Jan 2026	Japanese Patent Grant	Japanese Patent Grant
09/01/26	07:00:06	9 Jan 2026	Results of Shareholder Analysis	Results of Shareholder Analysis
15/12/25	14:29:32	15 Dec 2025	Result of Retail Offer	Result of Retail Offer
10/12/25	07:25:01	10 Dec 2025	Retail Offer	Retail Offer
10/12/25	07:00:09	10 Dec 2025	Placing of £1,000,000	Placing of £1,000,000
27/11/25	07:00:14	27 Nov 2025	Holding(s) in Company	Holding(s) in Company
30/10/25	07:00:11	30 Oct 2025	US Orphan Drug Designation Application	US Orphan Drug Designation Application
14/10/25	07:00:10	14 Oct 2025	Positive Preclinical Data in Prostate Cancer	Positive Preclinical Data in Prostate Cancer
15/09/25	07:00:10	15 Sept 2025	Half Year Report	Half Year Report
12/09/25	07:00:18	12 Sept 2025	Notice of Interim Results and IMC Presentation	Notice of Interim Results and IMC Presentation
01/09/25	07:00:10	1 Sept 2025	Approval for phase 2 clinical trial	Approval for phase 2 clinical trial
26/08/25	16:03:57	26 Aug 2025	Result of AGM	Result of AGM
26/08/25	07:00:06	26 Aug 2025	AGM Statement	AGM Statement
12/08/25	07:00:06	12 Aug 2025	GMP Manufacture of ChemoSeed	GMP Manufacture of ChemoSeed
04/08/25	17:45:00	4 Aug 2025	Notice of AGM and EMI Option Plan	Notice of AGM and EMI Option Plan
10/07/25	15:04:12	10 Jul 2025	Holding(s) in Company	Holding(s) in Company
03/07/25	07:00:10	3 Jul 2025	Result of Retail Offer and Additional Placing	Result of Retail Offer and Additional Placing
01/07/25	16:41:13	1 Jul 2025	Update presentation on the IMC platform	Update presentation on the IMC platform
01/07/25	07:00:08	1 Jul 2025	Submission of CTA Application	Submission of CTA Application
30/06/25	07:01:00	30 Jun 2025	Retail Offer	Retail Offer
30/06/25	07:00:11	30 Jun 2025	Placing	Placing
13/06/25	07:00:09	13 Jun 2025	Final Results for the year ended 31 December 2024	Final Results for the year ended 31 December 2024
09/06/25	07:00:10	9 Jun 2025	Best Paper Award	Best Paper Award
03/06/25	07:00:07	3 Jun 2025	Establishment of Scientific Advisory Board	Establishment of Scientific Advisory Board
07/04/25	11:46:21	7 Apr 2025	Director Dealing	Director Dealing
31/03/25	07:00:13	31 Mar 2025	Clinical Trial Update	Clinical Trial Update
27/03/25	07:00:04	27 Mar 2025	Innovate UK Grant Award	Innovate UK Grant Award
20/12/24	07:00:04	20 Dec 2024	Appointment of Specialist Clinical CRO	Appointment of Specialist Clinical CRO
18/12/24	07:00:02	18 Dec 2024	European Patent Grant	European Patent Grant
19/09/24	07:00:03	19 Sept 2024	Interim Results	Interim Results
09/09/24	07:00:10	9 Sept 2024	Notice of Interim Results & IMC Presentation	Notice of Interim Results & IMC Presentation
03/09/24	07:00:11	3 Sept 2024	Delivery Method Validated in Peer Reviewed Journal	Delivery Method Validated in Peer Reviewed Journal
02/09/24	07:00:09	2 Sept 2024	Innovation Passport Award	Innovation Passport Award

Date	Time	Date	TitleTitle (filtered)
02/07/26	16:31:03	2 Jul 2026	Holding(s) in Company	Holding(s) in Company
30/06/26	15:30:01	30 Jun 2026	Grant of Options	Grant of Options
26/06/26	07:00:03	26 Jun 2026	FINAL RESULTS	FINAL RESULTS
25/06/26	07:00:03	25 Jun 2026	Phase 2 Clinical Trial Progress Update	Phase 2 Clinical Trial Progress Update
22/06/26	08:49:42	22 Jun 2026	Holding(s) in Company	Holding(s) in Company
16/06/26	17:13:24	16 Jun 2026	Holding(s) in Company	Holding(s) in Company
15/06/26	11:15:01	15 Jun 2026	Result of General Meeting	Result of General Meeting
04/06/26	07:00:05	4 Jun 2026	Significant Grant Award	Significant Grant Award
01/06/26	07:00:12	1 Jun 2026	Grant Award	Grant Award
28/05/26	13:35:57	28 May 2026	Result of Retail Offer	Result of Retail Offer
27/05/26	09:34:33	27 May 2026	Notice of General Meeting	Notice of General Meeting
26/05/26	07:01:00	26 May 2026	Retail Offer to raise up to £100,000	Retail Offer to raise up to £100,000
26/05/26	07:00:14	26 May 2026	Placing of £2.5 million	Placing of £2.5 million
21/04/26	07:00:03	21 Apr 2026	Positive Preclinical Data for Docetaxel ChemoSeed	Positive Preclinical Data for Docetaxel ChemoSeed
02/04/26	07:00:05	2 Apr 2026	Board Changes	Board Changes
25/03/26	07:00:01	25 Mar 2026	Phase 2 Clinical Trial Progress Update	Phase 2 Clinical Trial Progress Update
17/03/26	07:00:14	17 Mar 2026	Awarding of Orphan Drug Designation by the FDA	Awarding of Orphan Drug Designation by the FDA
20/01/26	07:00:10	20 Jan 2026	Japanese Patent Grant	Japanese Patent Grant
09/01/26	07:00:06	9 Jan 2026	Results of Shareholder Analysis	Results of Shareholder Analysis
15/12/25	14:29:32	15 Dec 2025	Result of Retail Offer	Result of Retail Offer
10/12/25	07:25:01	10 Dec 2025	Retail Offer	Retail Offer
10/12/25	07:00:09	10 Dec 2025	Placing of £1,000,000	Placing of £1,000,000
27/11/25	07:00:14	27 Nov 2025	Holding(s) in Company	Holding(s) in Company
30/10/25	07:00:11	30 Oct 2025	US Orphan Drug Designation Application	US Orphan Drug Designation Application
14/10/25	07:00:10	14 Oct 2025	Positive Preclinical Data in Prostate Cancer	Positive Preclinical Data in Prostate Cancer
15/09/25	07:00:10	15 Sept 2025	Half Year Report	Half Year Report
12/09/25	07:00:18	12 Sept 2025	Notice of Interim Results and IMC Presentation	Notice of Interim Results and IMC Presentation
01/09/25	07:00:10	1 Sept 2025	Approval for phase 2 clinical trial	Approval for phase 2 clinical trial
26/08/25	16:03:57	26 Aug 2025	Result of AGM	Result of AGM
26/08/25	07:00:06	26 Aug 2025	AGM Statement	AGM Statement
12/08/25	07:00:06	12 Aug 2025	GMP Manufacture of ChemoSeed	GMP Manufacture of ChemoSeed
04/08/25	17:45:00	4 Aug 2025	Notice of AGM and EMI Option Plan	Notice of AGM and EMI Option Plan
10/07/25	15:04:12	10 Jul 2025	Holding(s) in Company	Holding(s) in Company
03/07/25	07:00:10	3 Jul 2025	Result of Retail Offer and Additional Placing	Result of Retail Offer and Additional Placing
01/07/25	16:41:13	1 Jul 2025	Update presentation on the IMC platform	Update presentation on the IMC platform
01/07/25	07:00:08	1 Jul 2025	Submission of CTA Application	Submission of CTA Application
30/06/25	07:01:00	30 Jun 2025	Retail Offer	Retail Offer
30/06/25	07:00:11	30 Jun 2025	Placing	Placing
13/06/25	07:00:09	13 Jun 2025	Final Results for the year ended 31 December 2024	Final Results for the year ended 31 December 2024
09/06/25	07:00:10	9 Jun 2025	Best Paper Award	Best Paper Award
03/06/25	07:00:07	3 Jun 2025	Establishment of Scientific Advisory Board	Establishment of Scientific Advisory Board
07/04/25	11:46:21	7 Apr 2025	Director Dealing	Director Dealing
31/03/25	07:00:13	31 Mar 2025	Clinical Trial Update	Clinical Trial Update
27/03/25	07:00:04	27 Mar 2025	Innovate UK Grant Award	Innovate UK Grant Award
20/12/24	07:00:04	20 Dec 2024	Appointment of Specialist Clinical CRO	Appointment of Specialist Clinical CRO
18/12/24	07:00:02	18 Dec 2024	European Patent Grant	European Patent Grant
19/09/24	07:00:03	19 Sept 2024	Interim Results	Interim Results
09/09/24	07:00:10	9 Sept 2024	Notice of Interim Results & IMC Presentation	Notice of Interim Results & IMC Presentation
03/09/24	07:00:11	3 Sept 2024	Delivery Method Validated in Peer Reviewed Journal	Delivery Method Validated in Peer Reviewed Journal
02/09/24	07:00:09	2 Sept 2024	Innovation Passport Award	Innovation Passport Award

Date	Time	Date	TitleTitle (filtered)
02/07/26	16:31:03	2 Jul 2026	Holding(s) in Company	Holding(s) in Company
30/06/26	15:30:01	30 Jun 2026	Grant of Options	Grant of Options
26/06/26	07:00:03	26 Jun 2026	FINAL RESULTS	FINAL RESULTS
25/06/26	07:00:03	25 Jun 2026	Phase 2 Clinical Trial Progress Update	Phase 2 Clinical Trial Progress Update
22/06/26	08:49:42	22 Jun 2026	Holding(s) in Company	Holding(s) in Company
16/06/26	17:13:24	16 Jun 2026	Holding(s) in Company	Holding(s) in Company
15/06/26	11:15:01	15 Jun 2026	Result of General Meeting	Result of General Meeting
04/06/26	07:00:05	4 Jun 2026	Significant Grant Award	Significant Grant Award
01/06/26	07:00:12	1 Jun 2026	Grant Award	Grant Award
28/05/26	13:35:57	28 May 2026	Result of Retail Offer	Result of Retail Offer
27/05/26	09:34:33	27 May 2026	Notice of General Meeting	Notice of General Meeting
26/05/26	07:01:00	26 May 2026	Retail Offer to raise up to £100,000	Retail Offer to raise up to £100,000
26/05/26	07:00:14	26 May 2026	Placing of £2.5 million	Placing of £2.5 million
21/04/26	07:00:03	21 Apr 2026	Positive Preclinical Data for Docetaxel ChemoSeed	Positive Preclinical Data for Docetaxel ChemoSeed
02/04/26	07:00:05	2 Apr 2026	Board Changes	Board Changes
25/03/26	07:00:01	25 Mar 2026	Phase 2 Clinical Trial Progress Update	Phase 2 Clinical Trial Progress Update
17/03/26	07:00:14	17 Mar 2026	Awarding of Orphan Drug Designation by the FDA	Awarding of Orphan Drug Designation by the FDA
20/01/26	07:00:10	20 Jan 2026	Japanese Patent Grant	Japanese Patent Grant
09/01/26	07:00:06	9 Jan 2026	Results of Shareholder Analysis	Results of Shareholder Analysis
15/12/25	14:29:32	15 Dec 2025	Result of Retail Offer	Result of Retail Offer
10/12/25	07:25:01	10 Dec 2025	Retail Offer	Retail Offer
10/12/25	07:00:09	10 Dec 2025	Placing of £1,000,000	Placing of £1,000,000
27/11/25	07:00:14	27 Nov 2025	Holding(s) in Company	Holding(s) in Company
30/10/25	07:00:11	30 Oct 2025	US Orphan Drug Designation Application	US Orphan Drug Designation Application
14/10/25	07:00:10	14 Oct 2025	Positive Preclinical Data in Prostate Cancer	Positive Preclinical Data in Prostate Cancer
15/09/25	07:00:10	15 Sept 2025	Half Year Report	Half Year Report
12/09/25	07:00:18	12 Sept 2025	Notice of Interim Results and IMC Presentation	Notice of Interim Results and IMC Presentation
01/09/25	07:00:10	1 Sept 2025	Approval for phase 2 clinical trial	Approval for phase 2 clinical trial
26/08/25	16:03:57	26 Aug 2025	Result of AGM	Result of AGM
26/08/25	07:00:06	26 Aug 2025	AGM Statement	AGM Statement
12/08/25	07:00:06	12 Aug 2025	GMP Manufacture of ChemoSeed	GMP Manufacture of ChemoSeed
04/08/25	17:45:00	4 Aug 2025	Notice of AGM and EMI Option Plan	Notice of AGM and EMI Option Plan
10/07/25	15:04:12	10 Jul 2025	Holding(s) in Company	Holding(s) in Company
03/07/25	07:00:10	3 Jul 2025	Result of Retail Offer and Additional Placing	Result of Retail Offer and Additional Placing
01/07/25	16:41:13	1 Jul 2025	Update presentation on the IMC platform	Update presentation on the IMC platform
01/07/25	07:00:08	1 Jul 2025	Submission of CTA Application	Submission of CTA Application
30/06/25	07:01:00	30 Jun 2025	Retail Offer	Retail Offer
30/06/25	07:00:11	30 Jun 2025	Placing	Placing
13/06/25	07:00:09	13 Jun 2025	Final Results for the year ended 31 December 2024	Final Results for the year ended 31 December 2024
09/06/25	07:00:10	9 Jun 2025	Best Paper Award	Best Paper Award
03/06/25	07:00:07	3 Jun 2025	Establishment of Scientific Advisory Board	Establishment of Scientific Advisory Board
07/04/25	11:46:21	7 Apr 2025	Director Dealing	Director Dealing
31/03/25	07:00:13	31 Mar 2025	Clinical Trial Update	Clinical Trial Update
27/03/25	07:00:04	27 Mar 2025	Innovate UK Grant Award	Innovate UK Grant Award
20/12/24	07:00:04	20 Dec 2024	Appointment of Specialist Clinical CRO	Appointment of Specialist Clinical CRO
18/12/24	07:00:02	18 Dec 2024	European Patent Grant	European Patent Grant
19/09/24	07:00:03	19 Sept 2024	Interim Results	Interim Results
09/09/24	07:00:10	9 Sept 2024	Notice of Interim Results & IMC Presentation	Notice of Interim Results & IMC Presentation
03/09/24	07:00:11	3 Sept 2024	Delivery Method Validated in Peer Reviewed Journal	Delivery Method Validated in Peer Reviewed Journal
02/09/24	07:00:09	2 Sept 2024	Innovation Passport Award	Innovation Passport Award